To the best of our knowledge, this is the first report to evaluate the association between RAN polymorphisms and CRC; we found RAN rs14035 CT heterozygotes and T allele carriers (CT + TT genotypes) had a lower CRC risk than individuals with other genotypes. Here, RAN is linked to colorectal carcinoma.